华中科技大学学报(医学版)
華中科技大學學報(醫學版)
화중과기대학학보(의학판)
ACTA UNIVERSITATIS MEDICINAE TONGJI
2015年
1期
42-46,73
,共6页
张翌%蔡逊%金炜东
張翌%蔡遜%金煒東
장익%채손%금위동
胃癌%多药耐药性%miRNA-106a%人类相关转录因子3
胃癌%多藥耐藥性%miRNA-106a%人類相關轉錄因子3
위암%다약내약성%miRNA-106a%인류상관전록인자3
gastric cancer%multidrug resistance%miRNA-106a%runt-related transcription factor 3
目的:探讨胃癌细胞中人类相关转录因子3(RUNX3)对miRNA‐106a(miR‐106a)表达的影响以及与多药耐药的关系。方法采用免疫印迹法及细胞凋亡检测来观察miR‐106a在两个人类胃癌细胞多药耐药细胞系上的表达情况。运用免疫印迹及多聚酶链式反应检测miR‐106a的表达来观察癌细胞对抗癌药物的敏感性。通过荧光素酶活性测定观察miR‐106a与RU NX3的关系。结果 miR‐106a在多药耐药胃癌细胞中表达增加,并抑制胃癌细胞对抗癌药物的敏感性;通过作用于RUNX3调节多药耐药。结论通过作用于RUNX3基因,miR‐106a诱导胃癌多药耐药性。
目的:探討胃癌細胞中人類相關轉錄因子3(RUNX3)對miRNA‐106a(miR‐106a)錶達的影響以及與多藥耐藥的關繫。方法採用免疫印跡法及細胞凋亡檢測來觀察miR‐106a在兩箇人類胃癌細胞多藥耐藥細胞繫上的錶達情況。運用免疫印跡及多聚酶鏈式反應檢測miR‐106a的錶達來觀察癌細胞對抗癌藥物的敏感性。通過熒光素酶活性測定觀察miR‐106a與RU NX3的關繫。結果 miR‐106a在多藥耐藥胃癌細胞中錶達增加,併抑製胃癌細胞對抗癌藥物的敏感性;通過作用于RUNX3調節多藥耐藥。結論通過作用于RUNX3基因,miR‐106a誘導胃癌多藥耐藥性。
목적:탐토위암세포중인류상관전록인자3(RUNX3)대miRNA‐106a(miR‐106a)표체적영향이급여다약내약적관계。방법채용면역인적법급세포조망검측래관찰miR‐106a재량개인류위암세포다약내약세포계상적표체정황。운용면역인적급다취매련식반응검측miR‐106a적표체래관찰암세포대항암약물적민감성。통과형광소매활성측정관찰miR‐106a여RU NX3적관계。결과 miR‐106a재다약내약위암세포중표체증가,병억제위암세포대항암약물적민감성;통과작용우RUNX3조절다약내약。결론통과작용우RUNX3기인,miR‐106a유도위암다약내약성。
Objective To explore the effect of miRNA‐106a(miR‐106a) expression on multidrug resistance(MDR)of gastric cancer(GC)cells and the involvement of runt‐related transcription factor 3 RUNX3.Methods The expression of miR‐106a was detected in two human gastric adenocarcinoma cell lines with MDR by immunoblotting and apoptosis assay. The sensitivity of GC cells to anticancer drugs was observed by detecting the expression of miR‐106a by using immunoblotting and PCR ,and the relationship between miR‐106a and RUNX3 was determined by luciferase activity assay.Results miR‐106a was significantly in‐creased in GC cells with MDR ,and it suppressed the sensitivity of GC cells to anticancer drugs. It could modulate MDR by tar‐geting RUNX3.Conclusion miR‐106a can induce the MDR by targeting RUNX3 in GC.